ArticleClinical proteomics2018
Identification of
Article in Clinical proteomics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 12 citations in OpenAlex.
- Utilization of qPCR and ELISA Tests to DetectVeterinary sciences · 2026Article
- Cytauxzoonosis in Indiana, USA: a case series of cats infected withJournal of feline medicine and surgery · 2024Article
- Naturally acquired adaptive immunity toClinical & translational immunology · 2024Article
- Article
- Article
- A Serodiagnostic IgM ELISA to Detect Acute Cytauxzoonosis.Pathogens (Basel, Switzerland) · 2022Article
- The Influence of B Cell Depletion Therapy on Naturally Acquired Immunity toFrontiers in immunology · 2020Article
- Second illness due to subsequentJFMS open reportsArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors at 5 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCytauxzoonosis is a disease of felids in North America caused by the tick-transmitted apicomplexan parasite
methodsRecent sequencing of the
resultsProbing of the protein microarray resulted in identification of 30 differentially reactive
conclusionsProtein microarray facilitated high-throughput identification of novel antigens, substantially increasing the pool of characterized
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.